Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1991 Apr 1;275(Pt 1):219–225. doi: 10.1042/bj2750219

Expression of human recombinant lipocortin I in a wheat-germ cell-free system and Xenopus oocytes. Lipocortin is not secreted.

B M Frey 1, F J Frey 1, V R Lingappa 1, H Trachsel 1
PMCID: PMC1150199  PMID: 1826832

Abstract

Lipocortin I has been presumed to be synthesized and secreted in response to glucocorticoids yet the amino acid sequence of lipocortin I reveals no signal sequence typically necessary for proteins to enter the secretory pathway. The translocation of lipocortin I across membranes was analyzed in a cell-free system and in Xenopus oocytes. Based on the published sequence, the cDNA of human lipocortin I was cloned and expressed in Escherichia coli. Lipocortin I was purified and used to raise monoclonal antibodies. To test whether lipocortin I is secreted in vitro, transcribed lipocortin mRNA was translated in a wheat germ cell-free system in the absence and presence of microsomal membranes. Prolactin mRNA was used as a control for translocation of newly synthesized protein into membrane vesicles. Prolactin, but not lipocortin I, was translocated into the membranes. To test for secretion of lipocortin I in vivo, Xenopus oocytes were co-injected with transcripts encoding lipocortin I and prolactin, with and without the signal sequence. Prolactin with the signal sequence was released into the medium. However, neither prolactin without a signal sequence nor lipocortin I was released. Carbonate extraction, using an integral transmembrane protein as control, revealed no evidence for membrane integration of lipocortin I. Thus lipocortin I is not a secreted protein.

Full text

PDF
219

Images in this article

221Fig. 1.
on p.221
222Fig. 2.
on p.222
222Fig. 3.
on p.222
223Fig. 4.
on p.223
224Fig. 5.
on p.224

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bienkowski M. J., Petro M. A., Robinson L. J. Inhibition of thromboxane A synthesis in U937 cells by glucocorticoids. Lack of evidence for lipocortin 1 as the second messenger. J Biol Chem. 1989 Apr 15;264(11):6536–6544. [PubMed] [Google Scholar]
  2. Blackwell G. J., Carnuccio R., Di Rosa M., Flower R. J., Ivanyi J., Langham C. S., Parente L., Persico P., Wood J. Suppression of arachidonate oxidation by glucocorticoid-induced antiphospholipase peptides. Adv Prostaglandin Thromboxane Leukot Res. 1983;11:65–71. [PubMed] [Google Scholar]
  3. Blackwell G. J., Carnuccio R., Di Rosa M., Flower R. J., Parente L., Persico P. Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature. 1980 Sep 11;287(5778):147–149. doi: 10.1038/287147a0. [DOI] [PubMed] [Google Scholar]
  4. Brönnegård M., Andersson O., Edwall D., Lund J., Norstedt G., Carstedt-Duke J. Human calpactin II (lipocortin I) messenger ribonucleic acid is not induced by glucocorticoids. Mol Endocrinol. 1988 Aug;2(8):732–739. doi: 10.1210/mend-2-8-732. [DOI] [PubMed] [Google Scholar]
  5. Cirino G., Flower R. J., Browning J. L., Sinclair L. K., Pepinsky R. B. Recombinant human lipocortin 1 inhibits thromboxane release from guinea-pig isolated perfused lung. Nature. 1987 Jul 16;328(6127):270–272. doi: 10.1038/328270a0. [DOI] [PubMed] [Google Scholar]
  6. Cirino G., Flower R. J. Human recombinant lipocortin 1 inhibits prostacyclin production by human umbilical artery in vitro. Prostaglandins. 1987 Jul;34(1):59–62. doi: 10.1016/0090-6980(87)90262-0. [DOI] [PubMed] [Google Scholar]
  7. Cirino G., Peers S. H., Flower R. J., Browning J. L., Pepinsky R. B. Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test. Proc Natl Acad Sci U S A. 1989 May;86(9):3428–3432. doi: 10.1073/pnas.86.9.3428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Davidson F. F., Dennis E. A., Powell M., Glenney J. R., Jr Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids. J Biol Chem. 1987 Feb 5;262(4):1698–1705. [PubMed] [Google Scholar]
  9. Dawid I. B., Sargent T. D. Xenopus laevis in developmental and molecular biology. Science. 1988 Jun 10;240(4858):1443–1448. doi: 10.1126/science.3287620. [DOI] [PubMed] [Google Scholar]
  10. Di Rosa M., Flower R. J., Hirata F., Parente L., Russo-Marie F. Anti-phospholipase proteins. Prostaglandins. 1984 Oct;28(4):441–442. doi: 10.1016/0090-6980(84)90232-6. [DOI] [PubMed] [Google Scholar]
  11. Errasfa M., Rothhut B., Fradin A., Billardon C., Junien J. L., Bure J., Russo-Marie F. The presence of lipocortin in human embryonic skin fibroblasts and its regulation by anti-inflammatory steroids. Biochim Biophys Acta. 1985 Nov 20;847(2):247–254. doi: 10.1016/0167-4889(85)90027-8. [DOI] [PubMed] [Google Scholar]
  12. Flower R. J., Blackwell G. J. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature. 1979 Mar 29;278(5703):456–459. doi: 10.1038/278456a0. [DOI] [PubMed] [Google Scholar]
  13. Fradin A., Rothhut B., Poincelot-Canton B., Errasfa M., Russo-Marie F. Inhibition of eicosanoid and PAF formation by dexamethasone in rat inflammatory polymorphonuclear neutrophils may implicate lipocortin 's'. Biochim Biophys Acta. 1988 Nov 25;963(2):248–257. doi: 10.1016/0005-2760(88)90288-3. [DOI] [PubMed] [Google Scholar]
  14. Glenney J., Zokas L. Antibodies to the N-terminus of calpactin II (p35) affect Ca2+ binding and phosphorylation by the epidermal growth factor receptor in vitro. Biochemistry. 1988 Mar 22;27(6):2069–2076. doi: 10.1021/bi00406a038. [DOI] [PubMed] [Google Scholar]
  15. Gupta C., Katsumata M., Goldman A. S., Herold R., Piddington R. Glucocorticoid-induced phospholipase A2-inhibitory proteins mediate glucocorticoid teratogenicity in vitro. Proc Natl Acad Sci U S A. 1984 Feb;81(4):1140–1143. doi: 10.1073/pnas.81.4.1140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gurdon J. B., Lane C. D., Woodland H. R., Marbaix G. Use of frog eggs and oocytes for the study of messenger RNA and its translation in living cells. Nature. 1971 Sep 17;233(5316):177–182. doi: 10.1038/233177a0. [DOI] [PubMed] [Google Scholar]
  17. Gurpide E., Markiewicz L., Schatz F., Hirata F. Lipocortin output by human endometrium in vitro. J Clin Endocrinol Metab. 1986 Jul;63(1):162–166. doi: 10.1210/jcem-63-1-162. [DOI] [PubMed] [Google Scholar]
  18. Hirata F., Iwata M. Role of lipomodulin, a phospholipase inhibitory protein, in immunoregulation by thymocytes. J Immunol. 1983 Apr;130(4):1930–1936. [PubMed] [Google Scholar]
  19. Hirata F. The regulation of lipomodulin, a phospholipase inhibitory protein, in rabbit neutrophils by phosphorylation. J Biol Chem. 1981 Aug 10;256(15):7730–7733. [PubMed] [Google Scholar]
  20. Hirata F., del Carmine R., Nelson C. A., Axelrod J., Schiffmann E., Warabi A., De Blas A. L., Nirenberg M., Manganiello V., Vaughan M. Presence of autoantibody for phospholipase inhibitory protein, lipomodulin, in patients with rheumatic diseases. Proc Natl Acad Sci U S A. 1981 May;78(5):3190–3194. doi: 10.1073/pnas.78.5.3190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hullin F., Raynal P., Ragab-Thomas J. M., Fauvel J., Chap H. Effect of dexamethasone on prostaglandin synthesis and on lipocortin status in human endothelial cells. Inhibition of prostaglandin I2 synthesis occurring without alteration of arachidonic acid liberation and of lipocortin synthesis. J Biol Chem. 1989 Feb 25;264(6):3506–3513. [PubMed] [Google Scholar]
  22. Katz F. N., Lodish H. F. Transmembrane biogenesis of the vesicular stomatitis virus glycoprotein. J Cell Biol. 1979 Feb;80(2):416–426. doi: 10.1083/jcb.80.2.416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Krieg P. A., Melton D. A. Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs. Nucleic Acids Res. 1984 Sep 25;12(18):7057–7070. doi: 10.1093/nar/12.18.7057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
  25. Lingappa V. R. Intracellular traffic of newly synthesized proteins. Current understanding and future prospects. J Clin Invest. 1989 Mar;83(3):739–751. doi: 10.1172/JCI113952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lundgren J. D., Hirata F., Marom Z., Logun C., Steel L., Kaliner M., Shelhamer J. Dexamethasone inhibits respiratory glycoconjugate secretion from feline airways in vitro by the induction of lipocortin (lipomodulin) synthesis. Am Rev Respir Dis. 1988 Feb;137(2):353–357. doi: 10.1164/ajrccm/137.2.353. [DOI] [PubMed] [Google Scholar]
  27. Maridonneau-Parini I., Errasfa M., Russo-Marie F. Inhibition of O2- generation by dexamethasone is mimicked by lipocortin I in alveolar macrophages. J Clin Invest. 1989 Jun;83(6):1936–1940. doi: 10.1172/JCI114101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Parente L., Di Rosea M., Flower R. J., Ghiara P., Meli R., Persico P., Salmon J. A., Wood J. N. Relationship between the anti-phospholipase and anti-inflammatory effects of glucocorticoid-induced proteins. Eur J Pharmacol. 1984 Mar 23;99(2-3):233–239. doi: 10.1016/0014-2999(84)90246-2. [DOI] [PubMed] [Google Scholar]
  29. Pepinsky R. B., Sinclair L. K., Browning J. L., Mattaliano R. J., Smart J. E., Chow E. P., Falbel T., Ribolini A., Garwin J. L., Wallner B. P. Purification and partial sequence analysis of a 37-kDa protein that inhibits phospholipase A2 activity from rat peritoneal exudates. J Biol Chem. 1986 Mar 25;261(9):4239–4246. [PubMed] [Google Scholar]
  30. Pfäffle M., Ruggiero F., Hofmann H., Fernández M. P., Selmin O., Yamada Y., Garrone R., von der Mark K. Biosynthesis, secretion and extracellular localization of anchorin CII, a collagen-binding protein of the calpactin family. EMBO J. 1988 Aug;7(8):2335–2342. doi: 10.1002/j.1460-2075.1988.tb03077.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Price P. A., Fraser J. D., Metz-Virca G. Molecular cloning of matrix Gla protein: implications for substrate recognition by the vitamin K-dependent gamma-carboxylase. Proc Natl Acad Sci U S A. 1987 Dec;84(23):8335–8339. doi: 10.1073/pnas.84.23.8335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Roman R., Brooker J. D., Seal S. N., Marcus A. Inhibition of the transition of a 40 S ribosome-Met-tRNA-i-Met complex to an 80 S ribosome-Met-tRNA-i-Met- complex by 7-Methylguanosine-5'-phosphate. Nature. 1976 Mar 25;260(5549):359–360. doi: 10.1038/260359a0. [DOI] [PubMed] [Google Scholar]
  33. Rosenberg A. H., Lade B. N., Chui D. S., Lin S. W., Dunn J. J., Studier F. W. Vectors for selective expression of cloned DNAs by T7 RNA polymerase. Gene. 1987;56(1):125–135. doi: 10.1016/0378-1119(87)90165-x. [DOI] [PubMed] [Google Scholar]
  34. Russo-Marie F., Duval D. Dexamethasone-induced inhibition of prostaglandin production dose not result from a direct action on phospholipase activities but is mediated through a steroid-inducible factor. Biochim Biophys Acta. 1982 Jul 20;712(1):177–185. doi: 10.1016/0005-2760(82)90100-x. [DOI] [PubMed] [Google Scholar]
  35. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Schwartz M. Sur l'existence chez Escherichia coli K 12 d'une régulation commune à la biosynthèse des récepteurs du bactériophage et au métabolisme du maltose. Ann Inst Pasteur (Paris) 1967 Nov;113(5):685–704. [PubMed] [Google Scholar]
  37. Silve S., Monod M., Hinnen A., Haguenauer-Tsapis R. The yeast acid phosphatase can enter the secretory pathway without its N-terminal signal sequence. Mol Cell Biol. 1987 Sep;7(9):3306–3314. doi: 10.1128/mcb.7.9.3306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Simon K., Perara E., Lingappa V. R. Translocation of globin fusion proteins across the endoplasmic reticulum membrane in Xenopus laevis oocytes. J Cell Biol. 1987 May;104(5):1165–1172. doi: 10.1083/jcb.104.5.1165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Solito E., Parente L. Modulation of phospholipase A2 activity in human fibroblasts. Br J Pharmacol. 1989 Mar;96(3):656–660. doi: 10.1111/j.1476-5381.1989.tb11865.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Studier F. W., Moffatt B. A. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol. 1986 May 5;189(1):113–130. doi: 10.1016/0022-2836(86)90385-2. [DOI] [PubMed] [Google Scholar]
  41. Verner K., Schatz G. Protein translocation across membranes. Science. 1988 Sep 9;241(4871):1307–1313. doi: 10.1126/science.2842866. [DOI] [PubMed] [Google Scholar]
  42. Wallner B. P., Mattaliano R. J., Hession C., Cate R. L., Tizard R., Sinclair L. K., Foeller C., Chow E. P., Browing J. L., Ramachandran K. L. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature. 1986 Mar 6;320(6057):77–81. doi: 10.1038/320077a0. [DOI] [PubMed] [Google Scholar]
  43. Walter P., Blobel G. Preparation of microsomal membranes for cotranslational protein translocation. Methods Enzymol. 1983;96:84–93. doi: 10.1016/s0076-6879(83)96010-x. [DOI] [PubMed] [Google Scholar]
  44. Zokas L., Glenney J. R., Jr The calpactin light chain is tightly linked to the cytoskeletal form of calpactin I: studies using monoclonal antibodies to calpactin subunits. J Cell Biol. 1987 Nov;105(5):2111–2121. doi: 10.1083/jcb.105.5.2111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. van Binsbergen J., Slotboom A. J., Aarsman A. J., de Haas G. H. Synthetic peptide from lipocortin I has no phospholipase A2 inhibitory activity. FEBS Lett. 1989 Apr 24;247(2):293–297. doi: 10.1016/0014-5793(89)81355-9. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES